Table 2.
NT-proBNP pg/mL | ||||||||||
Men | Women | |||||||||
age | n | 2.5th | median | 97.5th | range | n | 2.5th | median | 97.5th | range |
<50 | 78 | 5 | 24 | 93.2 | 5 ; 115 | 105 | 10.2 | 54 | 414 | 5 ; 578 |
50–54 | 110 | 5 | 25 | 88.8 | 5 ; 183 | 151 | 7 | 46 | 158.2 | 5 ; 200 |
55–59 | 156 | 5 | 29 | 153.28 | 5 ; 844 | 216 | 11.3 | 53 | 234.7 | 5 ; 332 |
60–64 | 182 | 9 | 36 | 269.57 | 5 ; 1121 | 205 | 13.03 | 62 | 283.35 | 5 ; 684 |
65–69 | 132 | 6.55 | 55.5 | 791.67 | 5 ; 1570 | 134 | 16.65 | 80.5 | 286.9 | 5 ; 850 |
70–74 | 58 | 10.4 | 61.5 | 660.12 | 5 ; 693 | 58 | 35.85 | 120.5 | 400.45 | 19 ; 3650 |
75–79 | 32 | 16.77 | 103 | 1247.32 | 16 ; 1741 | 33 | 28.6 | 168 | 1110.4 | 19 ; 2812 |
80–84 | 25 | 56.8 | 150 | 1061.8 | 40 ; 1276 | 35 | 33.8 | 159 | 588.6 | 44 ; 4141 |
85–89 | 31 | 60.5 | 264 | 1112.25 | 50 ; 1263 | 35 | 51.65 | 213 | 701.1 | 53 ; 5244 |
90–94 | 77 | 75.4 | 341 | 3001.4 | 44 ; 3165 | 53 | 82.2 | 311 | 1904.8 | 72 ; 8398 |
95–99 | 40 | 75.7 | 315.5 | 2154.32 | 25 ; 2401 | 44 | 104.3 | 360 | 2251.67 | 32 ; 8837 |
100+ | 9 | 287 | 644 | 3581.4 | 263 ; 3986 | 13 | 196.92 | 863 | 2449.17 | 79 ; 4307 |
SRAGE pg/mL | ||||||||||
Men | Women | |||||||||
age | n | 2.5th | median | 97.5th | range | n | 2.5th | median | 97.5th | range |
<50 | 87 | 210.15 | 399 | 794.95 | 72 ; 1910 | 130 | 238.35 | 479 | 1082.97 | 234 ; 1796 |
50–54 | 126 | 189.5 | 415 | 831.12 | 166 ; 2256 | 205 | 224.27 | 472 | 1225.45 | 165 ; 3411 |
55–59 | 209 | 202.12 | 418.5 | 866.62 | 100 ; 2104 | 319 | 214.6 | 495 | 1251 | 134 ; 2959 |
60–64 | 248 | 193 | 414 | 998.75 | 127 ; 3198 | 312 | 208.45 | 512.5 | 1431.15 | 28 ; 2665 |
65–69 | 199 | 208.1 | 421.5 | 1120.17 | 178 ; 5992 | 233 | 214 | 490 | 1561.6 | 161 ; 4776 |
70–74 | 104 | 205.3 | 423 | 885.32 | 148 ; 1416 | 103 | 218.65 | 511 | 1224.8 | 186 ; 1853 |
75–79 | 50 | 242.57 | 455.5 | 1347.65 | 217 ; 1789 | 72 | 212.17 | 566.5 | 1208.75 | 174 ; 3669 |
80–84 | 57 | 209.6 | 545 | 1390.2 | 170 ; 1443 | 88 | 220.5 | 603 | 1819.75 | 145 ; 5714 |
85–89 | 73 | 240 | 541 | 1638.6 | 156 ; 2307 | 108 | 274.9 | 687.5 | 1879.77 | 209 ; 5214 |
90–94 | 175 | 265.4 | 695 | 1745.7 | 172 ; 4837 | 164 | 263.5 | 661 | 1680.05 | 229 ; 4439 |
95–99 | 104 | 254.28 | 689 | 1990.77 | 189 ; 7944 | 159 | 325.8 | 763.5 | 1871.75 | 213 ; 6314 |
100+ | 13 | 307.1 | 727 | 2287.2 | 275 ; 2643 | 45 | 351.9 | 865 | 1784.47 | 245 ; 2864 |
The sample sizes per age groups vary because different diseases and treatment groups were found associated with nt-proBNP and SRAGE.